Breaking News

Saneca Expands R&D Capabilities

To drive R&D initiative following €1.5 million funding

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport. The funding has enabled the central-Europe based company to strengthen its pharmaceutical development services and establish a new R&D department, with 25 employees now based at its facility i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters